Product Description: TOK-8801 is a synthesized dihydroimidazothiazole carboxamide and is under development as an immunomodulator.
Applications: COVID-19-immunoregulation
Formula: C17H21N3OS
References: [1]Fujiwara M, et al. Immunomodulatory activity of the newly synthesized compound TOK-8801 (N-(2-phenylethyl)-3,6,6-trimethyl-5,6-dihydroimidazo[2,1-b]thiazole-2- carboxamide). Jpn J Pharmacol. 1989 Dec;51(4):549-54./[2]Shibata K, et al. Immunomodulatory effect of a newly synthesized compound, TOK-8801 (N-(2-phenylethyl)-3,6,6-trimethyl-5,6-dihydroimidazo [2,1-b]thiazole-2-carboxamide) on antibody production in vivo and delayed-type hypersensitivity in mice. Int J Immunopharmacol. 1990;12(5):497-502.
CAS Number: 105963-46-0
Molecular Weight: 315.43
Research Area: Inflammation/Immunology
Solubility: 10 mM in DMSO
Target: Others